Correlation Between Zentalis Pharmaceuticals and Atreca
Can any of the company-specific risk be diversified away by investing in both Zentalis Pharmaceuticals and Atreca at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Zentalis Pharmaceuticals and Atreca into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Zentalis Pharmaceuticals Llc and Atreca Inc, you can compare the effects of market volatilities on Zentalis Pharmaceuticals and Atreca and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Zentalis Pharmaceuticals with a short position of Atreca. Check out your portfolio center. Please also check ongoing floating volatility patterns of Zentalis Pharmaceuticals and Atreca.
Diversification Opportunities for Zentalis Pharmaceuticals and Atreca
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Zentalis and Atreca is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Zentalis Pharmaceuticals Llc and Atreca Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Atreca Inc and Zentalis Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Zentalis Pharmaceuticals Llc are associated (or correlated) with Atreca. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Atreca Inc has no effect on the direction of Zentalis Pharmaceuticals i.e., Zentalis Pharmaceuticals and Atreca go up and down completely randomly.
Pair Corralation between Zentalis Pharmaceuticals and Atreca
If you would invest (100.00) in Atreca Inc on December 4, 2024 and sell it today you would earn a total of 100.00 from holding Atreca Inc or generate -100.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
Zentalis Pharmaceuticals Llc vs. Atreca Inc
Performance |
Timeline |
Zentalis Pharmaceuticals |
Atreca Inc |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Zentalis Pharmaceuticals and Atreca Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Zentalis Pharmaceuticals and Atreca
The main advantage of trading using opposite Zentalis Pharmaceuticals and Atreca positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Zentalis Pharmaceuticals position performs unexpectedly, Atreca can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Atreca will offset losses from the drop in Atreca's long position.Zentalis Pharmaceuticals vs. Sana Biotechnology | Zentalis Pharmaceuticals vs. Olema Pharmaceuticals | Zentalis Pharmaceuticals vs. Cullinan Oncology LLC | Zentalis Pharmaceuticals vs. Monte Rosa Therapeutics |
Atreca vs. Passage Bio | Atreca vs. Stoke Therapeutics | Atreca vs. Revolution Medicines | Atreca vs. Black Diamond Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |